iTRAQ-based chromatin proteomic screen reveals CHD4-dependent recruitment of MBD2 to sites of DNA damage

Yazhou Sun1, Yeran Yang1, Hongyan Shen2

  • 1Key Laboratory of Genomic and Precision Medicine, China Gastrointestinal Cancer Research Center, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101, China; University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China.

Insights

Methyl-CpG-binding domain protein 2 (MBD2) is recruited to DNA damage sites, aiding cellular repair. Its knockdown increases sensitivity to genotoxic agents like mitomycin C.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • DNA repair proteins are crucial for cellular response to genotoxic stress.
  • Understanding these proteins aids in developing strategies against DNA-damaging agents.

Purpose of the Study:

  • To identify DNA repair proteins involved in the cellular response to mitomycin C (MMC).
  • To investigate the role of methyl-CpG-binding domain protein 2 (MBD2) in DNA damage response.

Main Methods:

  • Quantitative proteomic analysis of chromatin fractions after DNA damage.
  • Gene Ontology (GO) analysis to identify protein functions.
  • Laser microirradiation and CRISPR-Cas9 mediated knockdown for functional studies.

Main Results:

  • Identified 397 differentially enriched proteins, including chromatin modifiers and DNA repair factors.
  • MBD2 recruitment to DNA damage sites was observed, dependent on its MBD domain, C-terminus, poly(ADP-ribose), and CHD4.
  • Knockdown of MBD2 resulted in increased sensitivity to MMC in mammalian cells.

Conclusions:

  • MBD2 plays a significant role in the DNA damage response pathway.
  • MBD2's recruitment mechanism involves specific protein interactions and domains.
  • MBD2 is a potential therapeutic target for enhancing sensitivity to genotoxic cancer treatments.